The amoxicillin global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Amoxicillin Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The
amoxicillin market size has grown steadily in recent years. It will grow
from $4.58 billion in 2023 to $4.74 billion in 2024 at a compound
annual growth rate (CAGR) of 3.4%. The growth in the historic period can
be attributed to an increased understanding of antibiotics, a higher
pace of research activities and developments, increased cases of
cardiovascular diseases, increased demand for amoxicillin in the
treatment of urinary tract infections, rise in the aging population.
The amoxicillin market size is expected to see steady growth in the next few years. It will grow to $5.44 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to growing impaired renal function, prevalence of lower respiratory infections, increasing skin infections, growing cases of lower respiratory tract infections, and rising prevalence of bacterial infections. Major trends in the forecast period include demand for generic amoxicillin, focus on combination therapies, interest in probiotics and immunotherapy, demand for antibiotics, and advanced healthcare facilities.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/amoxicillin-global-market-report
Scope Of Amoxicillin Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Amoxicillin Market Overview
Market Drivers -
The
increasing prevalence of infectious diseases is expected to propel the
growth of the amoxicillin market going forward. Infectious diseases are
illnesses caused by pathogenic microorganisms such as bacteria, viruses,
fungi, or parasites. Cases of infectious diseases are rising due to
factors such as global travel, antimicrobial resistance, climate change
affecting disease vectors, and population density. Amoxicillin helps
treat infectious diseases by targeting bacterial cell wall synthesis,
leading to bacterial cell death. Its broad-spectrum activity, rapid
absorption, and ability to work synergistically with other antibiotics
make it a versatile and effective treatment for various bacterial
infections. For instance, in January 2023, according to the National
Institute of Health, a US-based public health research agency, urinary
tract infections ranked seventh among the leading reasons for emergency
department visits in the US, accounting for over 1 million visits
annually. Of these, 22% (220,000) were classified as complicated UTIs,
with approximately 100,000 cases resulting in hospital admissions each
year. Therefore, the increasing prevalence of infectious diseases is
driving the growth of the amoxicillin market.
Market Trends -
Major
companies operating in the amoxicillin market are developing innovative
drugs, such as reformulated versions of vonoprazan tablets, to enhance
the treatment of Helicobacter pylori infections and improve patient
outcomes. Vonoprazan is a novel potassium-competitive acid blocker
(PCAB), which is a new class of acid suppressant medication that is
reformulated. For instance, in May 2022, Phathom Pharmaceuticals, a
US-based pharmaceutical company, received the U.S. Food and Drug
Administration (FDA) approval of VOQUEZNA TRIPLE PAK (vonoprazan,
amoxicillin, clarithromycin) and VOQUEZNA DUAL PAK (vonoprazan,
amoxicillin) for the treatment of Helicobacter pylori (H. pylori)
infection in adults. These treatment regimens contain antibiotics
conveniently packaged with vonoprazan, a novel potassium-competitive
acid blocker (PCAB) and the first innovative acid suppressant from a new
drug class approved in the U.S. in over 30 years.
The amoxicillin market covered in this report is segmented –
1) By Drug Class: Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides
2) By Therapy Type: Monotherapy, Combinational Therapy
3) By Form: Tablets, Capsule, Suspensions, Syrup, Powder
4)
By Infection Type: Skin Infections, Ear, Nose And Throat Infections,
Stomach Infections, Lungs Infections, Urinary tract infections (UTI),
Pneumonia, Bronchitis, Gonorrhea
5) By End User: Hospitals , Homecare, Specialty Clinics, Other End Users
Get an inside scoop of the amoxicillin market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16336&type=smp
Regional Insights -
North
America was the largest region in the amoxicillin market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the
forecast period. The regions covered in the amoxicillin market report
are Asia-Pacific, Western Europe, Eastern Europe, North America, South
America, Middle East, Africa.
Key Companies -
Major companies
operating in the amoxicillin market are Pfizer Inc., Sanofi
S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Merck KGaA ,
Teva Pharmaceutical Industries Ltd. , Alkem Laboratories Ltd., Sun
Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited,
Torrent Pharmaceuticals GmbH, Aurobindo Pharma Limited, Hikma
Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, Daewoong
Pharmaceutical Co. Ltd., Centrient Pharmaceuticals, Wockhardt Limited,
Ranbaxy Laboratories Ltd., Atman Pharmaceuticals, Sinopharm Weiqida
Pharmaceutical Co. Ltd., Cipla Inc., Zydus Cadila
Table of Contents
1. Executive Summary
2. Amoxicillin Market Report Structure
3. Amoxicillin Market Trends And Strategies
4. Amoxicillin Market – Macro Economic Scenario
5. Amoxicillin Market Size And Growth
…..
27. Amoxicillin Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment